Open access peer-reviewed chapter

Gangliosides and Antigangliosides in Malignant Melanoma

By Corina-Daniela Ene (Nicolae) and Ilinca Nicolae

Submitted: May 27th 2014Reviewed: September 9th 2014Published: April 1st 2015

DOI: 10.5772/59176

Downloaded: 610

© 2015 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Corina-Daniela Ene (Nicolae) and Ilinca Nicolae (April 1st 2015). Gangliosides and Antigangliosides in Malignant Melanoma, Melanoma Mandi Murph, IntechOpen, DOI: 10.5772/59176. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

610total chapter downloads

2Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Melanoma — Epidemiology, Risk Factors, and the Role of Adaptive Pigmentation

By Erin M. Wolf Horrell, Kalin Wilson and John A. D’Orazio

Related Book

First chapter

Predictive Capacity and Functional Significance of MicroRNA in Human Melanoma

By Xiaobo Li and Yaguang Xi

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us